$Long Term Outcomes of Surgical Excision of Giant Papillae with Mitomycin C and Amniotic Membrane Transplantation in the Treatment of Refractory Palpebral Vernal Keratoconjunctivitis$

Long Term Outcomes of Surgical Excision of Giant Papillae with Mitomycin C and Amniotic Membrane Transplantation in the Treatment of Refractory Palpebral Vernal Keratoconjunctivitis

<i>Background and Objectives</i>: To report the long-term outcomes of patients with refractory Vernal Keratoconjunctivitis (VKC) who underwent surgical excision of giant papillae (GP) with mitomycin C (MMC) 0.02% and amniotic membrane transplantation (AMT). <i>Materials and Methods...

Bibliografski detalji
Glavni autori:	Moushmi Patil, Jodhbir S. Mehta
Format:	Članak
Jezik:	English
Izdano:	MDPI AG 2021-12-01
Serija:	Medicina
Teme:	vernal keratoconjunctivitis giant papillae amniotic membrane transplantation mitomycin C
Online pristup:	https://www.mdpi.com/1648-9144/58/1/19

Slični predmeti

Clinical pattern of vernal keratoconjunctivitis in children – A cross-sectional study
od: Roopa K, i dr.
Izdano: (2024-07-01)

An observational study on the presence of perilimbal conjunctival pigmentation in vernal keratoconjunctivitis
od: Srujana Dubbaka, i dr.
Izdano: (2023-01-01)

Comparative Efficacy and Safety of Topical Cyclosporine, Dexamethasone and Loteprednol in Vernal Keratoconjunctivitis
od: Muhammad Shahid Naeem, i dr.
Izdano: (2024-12-01)

Comparative Efficacy and Safety of Topical Cyclosporine, Dexamethasone and Loteprednol in Vernal Keratoconjunctivitis
od: Muhammad Shahid Naeem, i dr.
Izdano: (2024-12-01)

Ocular surface squamous neoplasia masquerading as pseudoepitheliomatous hyperplasia in chronic vernal keratoconjunctivitis
od: Ghosh Dastidar, Aditi, i dr.
Izdano: (2024-01-01)

Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives
od: DeGaulle I. Chigbu, i dr.
Izdano: (2021-07-01)

Classification of Subtypes of Vernal Keratoconjunctivitis by Cluster Analysis Based on Clinical Features
od: Fujita H, i dr.
Izdano: (2023-10-01)

Association of Vernal Keratoconjunctivitis (VKC) with Keratoconus in Patients Presenting to Ophthalmology Clinics of Rawal Institute of Health Sciences, Pakistan
od: Maham Zehra, i dr.
Izdano: (2024-04-01)

A Patient-Centered Approach to Vernal Keratoconjunctivitis (VKC): A Podcast
od: Ann Cathrine Larsen, i dr.
Izdano: (2024-03-01)

Demographic And Clinical Features Of Vernal Keratoconjunctivitis in a Hot Region: A Hospital-Based Study
od: Seyfettin Erdem
Izdano: (2019-10-01)

The Efficacy of Topical 0.03% Tacrolimus Dermatologic Ointment in Treatment of Vernal Keratoconjunctivitis
od: Muhammad Adnan, i dr.
Izdano: (2021-09-01)

Long-term efficacy of omalizumab in patients with conventional treatment-resistant vernal keratoconjunctivitis
od: Luis Santamaria, i dr.
Izdano: (2018-07-01)

To evaluate the effects of the application of 0.03% tacrolimus ointment in patients of vernal keratoconjunctivitis at a tertiary care hospital
od: Ajay V. Waghmare, i dr.
Izdano: (2024-09-01)

Vernal keratoconjunctivitis and eosinophilic esophagitis: A rare combination?
od: Maria Cristina Artesani, MD, i dr.
Izdano: (2024-01-01)

Vernal keratoconjunctivitis in adults: a narrative review of prevalence, pathogenesis, and management
od: Antonio Di Zazzo, i dr.
Izdano: (2024-02-01)

Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab
od: Serge Doan, MD, i dr.
Izdano: (2023-06-01)

Understanding Vernal Keratoconjunctivitis: Beyond Allergic Mechanisms
od: Marta Sacchetti, i dr.
Izdano: (2021-09-01)

Vernal Keratoconjunctivitis among Patients Presenting to the Outpatient Department of Ophthalmology of a Tertiary Care Centre: A Descriptive Cross-sectional Study
od: Neha Priyadarshani Chaudhary, i dr.
Izdano: (2023-01-01)

On the prevalence of vernal keratoconjunctivitis and current possibilities of treatment
od: V. V. Brzheskiy
Izdano: (2018-10-01)

Vernal keratoconjunctivitis: The burden of being allergic
od: Maria Cristina Artesani, MD, i dr.
Izdano: (2025-05-01)

Serum vitamin D levels in children with vernal keratoconjunctivitis – A study from a tertiary care pediatric hospital of North India
od: Meenakshi Wadhwani, i dr.
Izdano: (2024-05-01)

Cyclosporine A and autologous serum efficacy for treatment of vernal keratoconjunctivitis
od: Ahmed Esmail, i dr.
Izdano: (2024-05-01)

A comparative study of efficacy and effects on intraocular pressure following treatment with topical loteprednol etabonate (0.5%) versus fluorometholone acetate (0.1%) in vernal keratoconjunctivitis
od: Mita Saha Dutta Chowdhury, i dr.
Izdano: (2024-10-01)

Vernal Keratoconjunctivitis: Immunopathological Insights and Therapeutic Applications of Immunomodulators
od: Navpreet K. Hehar, i dr.
Izdano: (2024-03-01)

Prevalence and risk factors of Vernal Keratoconjunctivitis among a Ghanaian clinical cohort: A case‐control study
od: Samuel Kyei, i dr.
Izdano: (2024-03-01)

Pterygium Recurrence in Amniotic Membrane Graft and Mitomycin C Me-thods
od: Alireza Dehghani, i dr.
Izdano: (2011-04-01)

Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach
od: Daniele Giovanni Ghiglioni, i dr.
Izdano: (2020-04-01)

Reserve drug as first-line management: Topical interferon α-2b for vernal keratoconjunctivitis
od: Saurabh Ramdas Haral, i dr.
Izdano: (2024-03-01)

Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score
od: Andrea Leonardi, i dr.
Izdano: (2020-01-01)

Clinical Manifestations of Vernal Keratoconjunctivitis and Its Effects on School Attendance and Access to Medical Care in School Children of Western Uttar Pradesh
od: Mitali Yadav, i dr.
Izdano: (2024-10-01)

Long-Term Observation of Prognostic Factors and Clinical Outcome of Vernal Keratoconjunctivitis in Childhood
od: Shimokawa A, i dr.
Izdano: (2024-08-01)

A STUDY TO EVALUATE AND COMPARE THE EFFICACY AND SAFETY OF TOPICAL CYCLOSPORINE-A 0.5% WITH TOPICAL PLACEBO (ARTIFICIAL TEARS) IN ALLEVIATING THE CLINICAL FEATURES ASSOCIATED WITH VERNAL KERATOCONJUNCTIVITIS
od: Abha Gahlot, i dr.
Izdano: (2016-03-01)

Dendritic Cell Density and Morphology Can Be Used to Differentiate Vernal Keratoconjunctivitis from Allergic Conjunctivitis
od: Zahra Tajbakhsh, i dr.
Izdano: (2023-09-01)

Two cases of unilateral limbal Vernal keratoconjunctivitis in the same family: first case report
od: Paola Michieletto, i dr.
Izdano: (2023-10-01)

Self-retained, cryopreserved amniotic membrane for a scleral defect caused by mitomycin C: A case report
od: Brett Bielory
Izdano: (2024-12-01)

Ahmed glaucoma valve augmented with mitomycin C and amniotic membrane as a first intervention in advanced primary congenital glaucoma
od: Haytham M Ali, i dr.
Izdano: (2024-01-01)

Corticosteroid-sparing topical treatment with cyclosporin for juvenile keratoconjunctivitis
od: Amarilla Barcsay-Veres, i dr.
Izdano: (2025-02-01)

A Cross-Sectional Study to Evaluate the Refractive Status and Dry Eye Disease in Cases of Vernal Keratoconjunctivitis
od: Sanjeev Verma, i dr.
Izdano: (2024-12-01)

Assessment of the efficacy of olopatadine 0.1% in the treatment of vernal keratoconjunctivitis in terms of clinical improvement based on total ocular symptom score and ocular surface disease index
od: S Mohan, i dr.
Izdano: (2023-01-01)

Role of Damage-Associated Molecular Patterns (DAMPs/Alarmins) in Severe Ocular Allergic Diseases
od: Ken Fukuda, i dr.
Izdano: (2022-03-01)